Boehringer Wants Generic For Blockbuster Jardiance Blocked
Boehringer Ingelheim has hit an Arizona business with a patent lawsuit in Delaware federal court seeking to stop it from moving forward with a generic version of its diabetes drug Jardiance....To view the full article, register now.
Already a subscriber? Click here to view full article